Cinacalcet for the treatment of hyperparathyroidism in kidney transplant recipients: a systematic review and meta-analysis

JB Cohen, CE Gordon, EM Balk, JM Francis - Transplantation, 2012 - journals.lww.com
Background Hyperparathyroidism is present in up to 50% of transplant recipients 1 year after
transplant, often despite good graft function. Posttransplant patients frequently have …
被引用次数：81 相关文章

[引用][C] Cinacalcet for the Treatment of Hyperparathyroidism in Kidney Transplant Recipients: A Systematic Review and Meta-analysis

JB COHEN, CE GORDON, EM BALK… - …, 2012 - pascal-francis.inist.fr
Cinacalcet for the Treatment of Hyperparathyroidism in Kidney Transplant Recipients: A
Systematic Review and Meta-analysis CNRS Inist Pascal-Francis CNRS Pascal and …

[引用][C] Cinacalcet for the Treatment of Hyperparathyroidism in Kidney Transplant Recipients

JB Cohen, CE Gordon, EM Balk, JM Francis - Transplantation, 2012 - cir.nii.ac.jp
Cinacalcet for the Treatment of Hyperparathyroidism in Kidney Transplant Recipients | CiNii
Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 …

Cinacalcet for the treatment of hyperparathyroidism in kidney transplant recipients: a systematic review and meta-analysis.

JB Cohen, CE Gordon, EM Balk, JM Francis - Transplantation, 2012 - europepmc.org
Background Hyperparathyroidism is present in up to 50% of transplant recipients 1 year after
transplant, often despite good graft function. Posttransplant patients frequently have …

Cinacalcet for the treatment of hyperparathyroidism in kidney transplant recipients: a systematic review and meta-analysis

JB Cohen, CE Gordon, EM Balk, JM Francis - Transplantation, 2012 - hero.epa.gov
BACKGROUND: Hyperparathyroidism is present in up to 50% of transplant recipients 1 year
after transplant, often despite good graft function. Posttransplant patients frequently have …

Cinacalcet for the treatment of hyperparathyroidism in kidney transplant recipients: a systematic review and meta-analysis

JB Cohen, CE Gordon, EM Balk… - …, 2012 - pubmed.ncbi.nlm.nih.gov
Background Hyperparathyroidism is present in up to 50% of transplant recipients 1 year after
transplant, often despite good graft function. Posttransplant patients frequently have …